Investing to become financially independent
Investing to become financially independent
United Technologies Corporation, an American conglomerate based in Hartford, is an industrial giant present in five key sectors: HVAC, aeronautics, elevators, air navigation systems and helicopters through its subsidiary Sikorsky. Despite a prudent dividend policy, the company stands out for its successful diversification and resilience in the face of economic uncertainties, making it an attractive long-term investment.
United Technologies (NYSE:UTX) Read More »
Given the record and worrying strength of the Swiss franc, which is weighing on the performance of our portfolio and Swiss exporting companies, caution is required. Despite limited investment options in this context, particularly in luxury with Richemont or Swiss real estate, we remain patient while waiting for the next dividend distribution period.
Unhealthy strength of the Swiss franc Read More »
As promised, we are adding five new stocks to our portfolio this week: COP, UTX, PX, IBM and EMR. They join the latest newcomers, GD and AZN. All are listed on the NYSE and are considered by our algorithm as stocks to watch or hold if you already own them. We would have
Defensive stocks proved their resilience in the face of market turbulence caused by the Arab revolutions and disasters in Japan, with the portfolio growing despite oil's volatility. Our defensive, dividend-driven strategy continues to outperform the market, offering higher returns with lower volatility.
The best attack is defense Read More »
Since 2009, stock markets have risen spectacularly, with the SMI up 45% and the S&P 500 up 75%, raising legitimate concerns about current valuations. According to Warren Buffett's favorite indicator, the market is moderately overvalued, with a TMC/GNP ratio of 92.5%, suggesting a limited future annual return of 4.6%.
Market analysis: is it time to worry about overvaluation? Read More »
The portfolio suffered a drop in profitability to -4.74% following the fall of CenturyLink, but maintained a solid performance in euros with a Sharpe ratio higher than the benchmark indices. Dividends continue to rise, and new stocks such as Novartis and Roche are now being monitored to diversify the portfolio.
Released by CenturyLink... Read More »
The merger of Ciba-Geigy and Sandoz in 1996 gave rise to Novartis, now the world's 3rd largest pharmaceutical group. Despite its relative youth, the Basel-based company presents an attractive profile for investors, with a dividend yield of 3% and steadily increasing payouts.
Novartis (VTX:NOVN) Read More »
The week saw a slight increase in our portfolio despite a slight fall in the US dollar, with our first 2011 dividend distribution from ABT. Although the euro had a turbulent week, our Sharpe ratio remains higher than that of the CAC 40 thanks to better profitability and lower volatility.
Français 
English 
Italiano 
Deutsch 
Español 
Português